153 related articles for article (PubMed ID: 31232158)
1. Retrospective Analysis of Oxcarbazepine in Pregnant Women With Substance Use Disorders: Focus on Safety.
Johnson KD; Miller LN; Pouliot JD; Martin PR
J Pharm Pract; 2021 Feb; 34(1):28-34. PubMed ID: 31232158
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of oxcarbazepine in the treatment of focal epilepsy in neonates and infants under 3 months of age: A single-center retrospective analysis.
Ma Y; Deng J; Fu Z; Chen C; Wang X; Wang X; Weng J; Shen Y; Wang X; Fang F
Epilepsy Res; 2023 Nov; 197():107240. PubMed ID: 37852019
[TBL] [Abstract][Full Text] [Related]
3. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
[TBL] [Abstract][Full Text] [Related]
4. Oxcarbazepine and Hyponatremia.
Čiauškaitė J; Gelžinienė G; Jurkevičienė G
Medicina (Kaunas); 2022 Apr; 58(5):. PubMed ID: 35629976
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the efficacy and tolerability of oxcarbazepine oral suspension between infants and children with epilepsy: a retrospective chart review at a single medical center in Taiwan.
Wei SH; Liu CC; Fan PC
Paediatr Drugs; 2014 Feb; 16(1):83-9. PubMed ID: 24081427
[TBL] [Abstract][Full Text] [Related]
6. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
Löfgren E; Tapanainen JS; Koivunen R; Pakarinen A; Isojärvi JI
Epilepsia; 2006 Sep; 47(9):1441-6. PubMed ID: 16981858
[TBL] [Abstract][Full Text] [Related]
9. Oxcarbazepine in bipolar disorder: a critical review of the literature.
Mazza M; Di Nicola M; Martinotti G; Taranto C; Pozzi G; Conte G; Janiri L; Bria P; Mazza S
Expert Opin Pharmacother; 2007 Apr; 8(5):649-56. PubMed ID: 17376019
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital.
Lee JE; Min KR; Kim SH; Kim AH; Kim ST
Yonsei Med J; 2020 Oct; 61(10):875-879. PubMed ID: 32975062
[TBL] [Abstract][Full Text] [Related]
12. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
[TBL] [Abstract][Full Text] [Related]
13. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic drugs-induced hyponatremia: Review and analysis of 560 hospitalized patients.
Intravooth T; Staack AM; Juerges K; Stockinger J; Steinhoff BJ
Epilepsy Res; 2018 Jul; 143():7-10. PubMed ID: 29631131
[TBL] [Abstract][Full Text] [Related]
15. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
[TBL] [Abstract][Full Text] [Related]
16. Association of oxcarbazepine concentration with seizure frequency in pregnant women with epilepsy.
Wei LY; Xu ZY; Lai ZZ; Dong N; Sang YW; Guo Y
Epilepsy Behav Rep; 2024; 25():100640. PubMed ID: 38235017
[TBL] [Abstract][Full Text] [Related]
17. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
[TBL] [Abstract][Full Text] [Related]
19. Effects of UGT1A9 genetic polymorphisms on monohydroxylated derivative of oxcarbazepine concentrations and oxcarbazepine monotherapeutic efficacy in Chinese patients with epilepsy.
Lu Y; Fang Y; Wu X; Ma C; Wang Y; Xu L
Eur J Clin Pharmacol; 2017 Mar; 73(3):307-315. PubMed ID: 27900402
[TBL] [Abstract][Full Text] [Related]
20. [Oxcarbazepine in the treatment of epilepsy].
Freidel M; Krause E; Kuhn K; Peper R; Vogel H
Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
